GLP1R and obesity due to melanocortin 4 receptor deficiency: Chronic treatment with GLP-1 receptor agonists has been reported to improve reproductive hormone levels in hypogonadal men with obesity and/or type 2 diabetes, but this may be a consequence of the weight loss associated with GLP-1 receptor agonists (25, 26).